Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307)
CompletedOBSERVATIONAL
Enrollment
42
Participants
Timeline
Start Date
July 1, 2013
Primary Completion Date
December 18, 2017
Study Completion Date
December 18, 2017
Conditions
Bipolar DisorderSchizophrenia
All Listed Sponsors
lead
Organon and Co
INDUSTRY
NCT01495741 - Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307) | Biotech Hunter | Biotech Hunter